Not applicableWithdrawnNCT05426213What this trial is testingRobot-Assisted Bronchoscopy in Chinese Participants With Lung LesionsWho this might be right forLung Neoplasms Auris Health, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT02025218What this trial is testingIressa Re-challenge in Advanced NSCLC EGFR-mutated PatientsWho this might be right forLung Cancer Amsterdam UMC, location VUmc 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186974What this trial is testingStudy of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer Gilead Sciences 193
Testing effectiveness (Phase 2)UnknownNCT04776590What this trial is testingChemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal CancerWho this might be right forEsophagus CancerNeoadjuvant Therapy Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Large-scale testing (Phase 3)Study completedNCT01661790What this trial is testingIntrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung CancerWho this might be right forMalignant Pleural Effusion Chinese PLA General Hospital 72
Large-scale testing (Phase 3)Active Not RecruitingNCT05671510What this trial is testingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsWho this might be right forNon Small Cell Lung Cancer OncoC4, Inc. 630
Not applicableEnded earlyNCT04718610What this trial is testingHeart Rate Variability, Vagus Nerve and CancerWho this might be right forLung CancerColorectal CancerMultiple Myeloma+1 more Centre Hospitalier Henri Duffaut - Avignon 25
Testing effectiveness (Phase 2)UnknownNCT02967497What this trial is testingClinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild TypeWho this might be right forEpithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer Taipei Veterans General Hospital, Taiwan 56
Early research (Phase 1)Study completedNCT00986297What this trial is testingSpecialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance StatusWho this might be right forLung Cancer University of Texas Southwestern Medical Center 60
Not applicableLooking for participantsNCT07827183What this trial is testingAI-Personalized Discharge Education for Patients After Lung Cancer SurgeryWho this might be right forLung Cancer (Diagnosis) Xiamen University 156
Early research (Phase 1)UnknownNCT05826483What this trial is testingAlmonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance StatusWho this might be right forMalignant Tumor of LungPoor Performance Status Guangzhou Institute of Respiratory Disease 20
Early research (Phase 1)Ended earlyNCT03255083What this trial is testingDS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) Daiichi Sankyo 13
Testing effectiveness (Phase 2)Study completedNCT00509041What this trial is testingDasatinib in Treating Patients With Previously Treated Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Looking for participantsNCT06095505What this trial is testingAlisertib in Patients With Extensive Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer Puma Biotechnology, Inc. 120
Not applicableStudy completedNCT02459002What this trial is testingProspective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot ProjectWho this might be right forLung CancerNon-small Cell Lung Cancer M.D. Anderson Cancer Center 209
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Very early researchStudy completedNCT00743353What this trial is testingExploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5Who this might be right forSarcomaMelanomaLung Cancer+2 more Siemens Molecular Imaging 16
Post-approval studies (Phase 4)Study completedNCT03570645What this trial is testingComparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral BlockWho this might be right forLung Cancer China Medical University, China 154
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Not applicableLooking for participantsNCT03199651What this trial is testingBeating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerWho this might be right forCigarette SmokerCurrent SmokerLung Adenocarcinoma+2 more Ohio State University Comprehensive Cancer Center 3,584